The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Payments of Debt: BDT0.00 Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:IBNSINA The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
21 GF Score
Price BDT332.60
View Full Analysis

What is The IBN SINA Pharmaceutical Industry Payments of Debt?

The IBN SINA Pharmaceutical Industry DHA:IBNSINA -1.80% 21 Payments of Debt is BDT0.00 Mil as of . 20. GuruFocus rates DHA:IBNSINA with a GF Score™ of 21/100.

The IBN SINA Pharmaceutical Industry's Payments of Debt for the six months ended in . 20 was BDT0.00 Mil.

The IBN SINA Pharmaceutical Industry's Payments of Debt for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

The IBN SINA Pharmaceutical Industry Payments of Debt Related Terms

The IBN SINA Pharmaceutical Industry Payments of Debt Historical Data

* Premium members only.

The historical data trend for The IBN SINA Pharmaceutical Industry's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The IBN SINA Pharmaceutical Industry Payments of Debt Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
Payments of Debt

The IBN SINA Pharmaceutical Industry Semi-Annual Data
Payments of Debt
DHA:IBNSINA
21GF Score
The IBN SINA Pharmaceutical Industry PLC DHA:IBNSINA
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The IBN SINA Pharmaceutical Industry Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Payments of Debt for the trailing twelve months (TTM) ended in . 20 was BDT0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of BDT0.00 Mil mean?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a Payments of Debt of BDT0.00 Mil as of . 20. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on The IBN SINA Pharmaceutical Industry and its competitors.
Is The IBN SINA Pharmaceutical Industry's Payments of Debt too high?
The IBN SINA Pharmaceutical Industry's current Payments of Debt is BDT0.00 Mil. Overall, The IBN SINA Pharmaceutical Industry has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does The IBN SINA Pharmaceutical Industry's Payments of Debt compare to IMNPQ?
The IBN SINA Pharmaceutical Industry's Payments of Debt of BDT0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Drug Manufacturers company?
A good Payments of Debt depends on the Drug Manufacturers industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on The IBN SINA Pharmaceutical Industry and its competitors. The IBN SINA Pharmaceutical Industry's current Payments of Debt is BDT0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The IBN SINA Pharmaceutical Industry stock overvalued right now?
The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) has a current Payments of Debt of BDT0.00 Mil. The current Payments of Debt is BDT0.00 Mil. The IBN SINA Pharmaceutical Industry's overall GF Score™ is 21/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For The IBN SINA Pharmaceutical Industry (DHA:IBNSINA), the current Payments of Debt is BDT0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The IBN SINA Pharmaceutical Industry Business Description

Address Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.
21GF Score

Get the complete analysis for DHA:IBNSINA

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT332.60
Price